Literature DB >> 24677774

Amelioration of the typical cognitive phenotype in a patient with the 5pter deletion associated with Cri-du-chat syndrome in addition to a partial duplication of CTNND2.

Jennifer M Sardina1, Allyson R Walters, Kathryn E Singh, Renius X Owen, Virginia E Kimonis.   

Abstract

Cri-du-chat is a rare congenital syndrome characterized by intellectual disability, severe speech/developmental delay, dysmorphic features, and additional syndromic findings. The etiology of this disorder is well known, and is attributed to a large deletion on chromosome 5 that typically ranges from band 5p15.2 to the short arm terminus. This region contains CTNND2, a gene encoding a neuronal-specific protein, delta-catenin, which plays a critical role in cellular motility and brain function. The exact involvement of CTNND2 in the cognitive functionality of individuals with Cri-du-chat has not been fully deciphered, but it is thought to be significant. This report describes an 8-year-old African-American female with a complex chromosome 5 abnormality and a relatively mild case of cri-du-chat syndrome. Because of the surprisingly mild cognitive phenotype, although a karyotype had confirmed the 5p deletion at birth, an oligo-SNP microarray was obtained to further characterize her deletion. The array revealed a complex rearrangement, including a breakpoint in the middle of CTNND2, which resulted in a partial deletion and partial duplication of that gene. The array also verified the expected 5p terminal deletion. Although the patient has a significant deletion in CTNND2, half of the gene (including the promoter region) is not only preserved, but is duplicated. The patient's milder cognitive and behavioral presentation, in conjunction with her atypical 5p alteration, provides additional evidence for the role of CTNND2 in the cognitive phenotype of individuals with Cri-du-chat.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  5p deletion syndrome; 5p minus syndrome; CTNND2 protein, human; Chromosome 5; Cri-du-chat syndrome; DNA microarrays; catenin (cadherin-associated protein), delta 2, human; catenin delta 2, human; cognitive phenotype; intellectual disability; oligo-SNP microarrays; partial duplication

Mesh:

Substances:

Year:  2014        PMID: 24677774     DOI: 10.1002/ajmg.a.36494

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  δ-Catenin Regulates Spine Architecture via Cadherin and PDZ-dependent Interactions.

Authors:  Li Yuan; Eunju Seong; James L Beuscher; Jyothi Arikkath
Journal:  J Biol Chem       Date:  2015-02-27       Impact factor: 5.157

Review 2.  Functional roles of p120ctn family of proteins in central neurons.

Authors:  Li Yuan; Jyothi Arikkath
Journal:  Semin Cell Dev Biol       Date:  2017-06-09       Impact factor: 7.727

Review 3.  Delta-Catenin as a Modulator of Rho GTPases in Neurons.

Authors:  Maxsam S Donta; Yogesh Srivastava; Pierre D McCrea
Journal:  Front Cell Neurosci       Date:  2022-07-04       Impact factor: 6.147

Review 4.  5p deletions: Current knowledge and future directions.

Authors:  Joanne M Nguyen; Krista J Qualmann; Rebecca Okashah; AmySue Reilly; Mikhail F Alexeyev; Dennis J Campbell
Journal:  Am J Med Genet C Semin Med Genet       Date:  2015-08-03       Impact factor: 3.908

Review 5.  Genetic alterations of δ-catenin/NPRAP/Neurojungin (CTNND2): functional implications in complex human diseases.

Authors:  Qun Lu; Byron J Aguilar; Mingchuan Li; Yongguang Jiang; Yan-Hua Chen
Journal:  Hum Genet       Date:  2016-07-05       Impact factor: 4.132

6.  Clinical and molecular characterization of 12 prenatal cases of Cri-du-chat syndrome.

Authors:  Ying Peng; Jialun Pang; Jiancheng Hu; Zhengjun Jia; Hui Xi; Na Ma; Shuting Yang; Jing Liu; Xiaoliang Huang; Chengyuan Tang; Hua Wang
Journal:  Mol Genet Genomic Med       Date:  2020-06-04       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.